The SPORE Program Receives Grant for Lymphoma Research
4. Genomic Predictors of Early Relapse in Immunochemotherapy-Treated Follicular Lymphoma
Follicular lymphoma is a common non-Hodgkin lymphoma and has highly variable treatment results. This study seeks to examine, validate, and integrate clinical, tumor, and genetic biomarkers into clinical information that can help doctors in a number of ways. It can help doctors determine whether a patient is high or low risk as well as accurately predicting survival rate. This study mainly focuses on follicular lymphoma patients that had early clinical failures.